Skip to Content
Merck
CN

Dysregulated actin dynamics in activated PI3Kδ syndrome.

Clinical immunology (Orlando, Fla.) (2019-11-25)
Jacqueline G Wallace, Pedro Zambrano-Rodas, Wilmer Córdova-Calderón, Santiago Estrada-Turriate, Daniel Mendoza-Quispe, Yesenia Limache Ontiveros, Raif S Geha, Janet Chou, Craig D Platt
ABSTRACT

Activated PI3Kδ syndrome (APDS) Type I results from gain-of-function mutations in PIK3CD, which encodes the p110δ subunit of PI3Kδ. Abnormal actin dynamics have been hypothesized to contribute to the lymphopenia associated with this disease but have not been studied in patients with APDS. We report a patient with APDS who had widespread necrotic skin lesions that were responsive specifically to immunosuppressive therapy. EBV-transformed lymphoblastoid cells (EBV-LCLs) from patients with APDS exhibit increased polymerized actin and increased apoptosis, suggesting a contribution of impaired actin dynamics to this disease.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Phalloidin, Fluorescein Isothiocyanate Labeled, sequence Amanita phalloides(synthetic: peptide sequence)